Sequana Medical NV (SEQUA) — Strategic Asset Allocation Index
Sequana Medical NV (SEQUA) has a Strategic Asset Allocation Index of 15.7% as of June 2022. Strategic assets (PP&E of €2.04 Million plus long-term investments of €-) total €2.04 Million, measured against net assets of €12.99 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Sequana Medical NV Strategic Asset Allocation Index (2019–2020)
This chart shows how Sequana Medical NV's Strategic Asset Allocation Index has evolved across 2 annual periods from 2019 to 2020. As of June 2022, the index stands at 15.7%, representing strategic assets of €2.04 Million against net assets of €12.99 Million EUR. Explore SEQUA operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Sequana Medical NV (2019–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Sequana Medical NV from 2019 to 2020, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see SEQUA market cap overview.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 625.0% | €704.72K | €704.72K | €- | €112.76K | ▲ +559.4 pp |
| 2019 | 65.5% | €606.70K | €606.70K | €- | €925.93K | — |